25.59
-2.11
(-7.63%)
As of 12:29:01 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-389,841
-389,841
-296,062
-309,478
-407,320
Investing Cash Flow
363,441
363,441
239,575
243,261
1,248,778
Financing Cash Flow
14,442
14,442
5,433
2,350
-765,768
End Cash Position
76,247
76,247
88,205
139,259
203,126
Income Tax Paid Supplemental Data
43,150
43,150
1,569
--
16,078
Capital Expenditure
-1,685
-1,685
-18,499
-4,881
-5,741
Repayment of Debt
--
--
--
-331
-578
Repurchase of Capital Stock
--
--
--
--
-802,486
Free Cash Flow
-391,526
-391,526
-314,561
-314,359
-413,061
12/31/2021 - 7/24/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
RARE Ultragenyx Pharmaceutical Inc.
33.23
-5.41%
PTCT PTC Therapeutics, Inc.
44.28
-5.24%
BPMC Blueprint Medicines Corporation
82.21
-5.62%
FOLD Amicus Therapeutics, Inc.
7.56
-5.56%
KYMR Kymera Therapeutics, Inc.
22.15
-6.50%
VERA Vera Therapeutics, Inc.
21.09
-7.28%
XENE Xenon Pharmaceuticals Inc.
29.73
-3.21%
DYN Dyne Therapeutics, Inc.
8.28
-12.10%
MRUS Merus N.V.
37.88
-9.23%
KRYS Krystal Biotech, Inc.
169.48
-4.86%